Walsh & Associates’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.9K Hold
182
– – 0.02% 156
2026
Q2
$26.6K Hold
182
– – 0.02% 151
2026
Q1
$22.8K Hold
182
– – 0.02% 152
2025
Q4
$21.9K Hold
182
– – 0.02% 154

Other funds holding IVOG

Walsh & Associates's IVOG Position: Q3 2026 in Review

Walsh & Associates held its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) position steady in Q3 2026 at 182 shares worth $24.9K. The position accounts for 0.02% of the portfolio, ranked #156.

Walsh & Associates first reported a position in IVOG in Q4 2025 and has held it in 4 quarters since. The position peaked at $26.6K in Q2 2026. 192 funds tracked by Wall St. Rank hold IVOG as of Q3 2026.

  • Walsh & Associates held 182 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $24.9K as of Q3 2026.
  • Walsh & Associates left its Vanguard S&P Mid-Cap 400 Growth ETF share count unchanged in Q3 2026.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up 0.02% of Walsh & Associates's portfolio in Q3 2026, its #156 holding.
  • Walsh & Associates first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2025 and has held it in 4 quarters since.
  • Walsh & Associates's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $26.6K in Q2 2026.
  • 192 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.